Outlining three practices that are key to navigating today’s multiplayer agency landscape - and getting more value from each external vendor.
Justin Grossman
Advertisement
Justin Grossman is Managing Partner, multimedia.
Articles by Justin Grossman
Clinical trials for precision therapies will require a healthy dose of education, collaboration, and data-driven decision-making from everyone involved in the process―not to mention a dedication to digital technology. Justin Grossman reports.
Creating a culture of analytics will help you get the most out of your marketing efforts, writes Justin Grossman.
Advertisement
Latest Updated Articles
- How to Get Your Marketing Team to Drive with Data
Published: March 8th 2019 | Updated:
How Precision Medicine Will Revolutionize Trial RecruitmentPublished: March 20th 2019 | Updated:
Three Tips to Managing Multiple Agency PartnersPublished: August 1st 2019 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
5
